These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26458831)

  • 1. Polymerase Mechanism-Based Method of Viral Attenuation.
    Lee CA; August A; Arnold JJ; Cameron CE
    Methods Mol Biol; 2016; 1349():83-104. PubMed ID: 26458831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.
    Trobaugh DW; Sun C; Dunn MD; Reed DS; Klimstra WB
    PLoS Pathog; 2019 Feb; 15(2):e1007584. PubMed ID: 30742691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering attenuated virus vaccines by controlling replication fidelity.
    Vignuzzi M; Wendt E; Andino R
    Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype.
    Naito T; Shirai K; Mori K; Muratsu H; Ushirogawa H; Ohniwa RL; Hanada K; Saito M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.
    Meng T; Kwang J
    J Virol; 2014 May; 88(10):5803-15. PubMed ID: 24623423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.
    Iwasaki M; Ngo N; Cubitt B; Teijaro JR; de la Torre JC
    J Virol; 2015 Dec; 89(23):12166-77. PubMed ID: 26401045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.
    Li J; Arévalo MT; Diaz-Arévalo D; Chen Y; Choi JG; Zeng M
    J Control Release; 2015 Jun; 207():70-6. PubMed ID: 25858415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design.
    Gardner CL; Hritz J; Sun C; Vanlandingham DL; Song TY; Ghedin E; Higgs S; Klimstra WB; Ryman KD
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2719. PubMed ID: 24587470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
    Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
    J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate.
    Wang B; Yang C; Tekes G; Mueller S; Paul A; Whelan SP; Wimmer E
    mBio; 2015 Mar; 6(2):. PubMed ID: 25827413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host defense mechanism-based rational design of live vaccine.
    Jang YH; Byun YH; Lee KH; Park ES; Lee YH; Lee YJ; Lee J; Kim KH; Seong BL
    PLoS One; 2013; 8(10):e75043. PubMed ID: 24098364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationalizing the development of live attenuated virus vaccines.
    Lauring AS; Jones JO; Andino R
    Nat Biotechnol; 2010 Jun; 28(6):573-9. PubMed ID: 20531338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA Polymerase.
    Liu X; Musser DM; Lee CA; Yang X; Arnold JJ; Cameron CE; Boehr DD
    Viruses; 2015 Oct; 7(10):5571-86. PubMed ID: 26516899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foot-and-mouth disease virus low-fidelity polymerase mutants are attenuated.
    Xie X; Wang H; Zeng J; Li C; Zhou G; Yang D; Yu L
    Arch Virol; 2014 Oct; 159(10):2641-50. PubMed ID: 24888311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Polymerase mechanism-based strategy for viral attenuation and vaccine development.
    Weeks SA; Lee CA; Zhao Y; Smidansky ED; August A; Arnold JJ; Cameron CE
    J Biol Chem; 2012 Sep; 287(38):31618-22. PubMed ID: 22854962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity.
    Liu X; Yang X; Lee CA; Moustafa IM; Smidansky ED; Lum D; Arnold JJ; Cameron CE; Boehr DD
    J Biol Chem; 2013 Nov; 288(45):32753-32765. PubMed ID: 24085299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.
    Zeng J; Wang H; Xie X; Li C; Zhou G; Yang D; Yu L
    J Virol; 2014 Apr; 88(8):4008-20. PubMed ID: 24453363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.
    Vignuzzi M; Stone JK; Andino R
    Virus Res; 2005 Feb; 107(2):173-81. PubMed ID: 15649563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the full genetic information of Japanese rubella vaccines and the genetic changes associated with in vitro and in vivo vaccine virus phenotypes.
    Otsuki N; Abo H; Kubota T; Mori Y; Umino Y; Okamoto K; Takeda M; Komase K
    Vaccine; 2011 Feb; 29(10):1863-73. PubMed ID: 21251900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.